- Filed
- May 8, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · May 2, 2023 | 38.59M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2023 | 44.65M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2022 | 49.75M sh |
| Stock Repurchased | Q1 2023 · Mar 31, 2023 | $276.95M |
| Stock Repurchased | Q1 2023 · Mar 31, 2022 | $30.54M |
| Capex | Q1 2023 · Mar 31, 2023 | $2.54M |
| Capex restated | Q1 2023 · Mar 31, 2022 | $3.85M |
| Long Term Debt | Q1 2023 · Mar 31, 2023 | $157.68M |
| Long Term Debt | Q1 2023 · Dec 31, 2022 | $0 |
| Short Term Debt | Q1 2023 · Mar 31, 2023 | $5.31M |
| Short Term Debt | Q1 2023 · Dec 31, 2022 | $0 |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $144.96M |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $263.93M |
| Stockholders Equity | Q1 2023 · Mar 31, 2023 | $468.04M |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | $743.2M |
| Stockholders Equity | Q1 2023 · Mar 31, 2022 | $348.87M |
| Stockholders Equity | Q1 2023 · Dec 31, 2021 | $341.62M |
| Current Liabilities | Q1 2023 · Mar 31, 2023 | $146.62M |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $142.29M |
| Total Liabilities | Q1 2023 · Mar 31, 2023 | $379.23M |
| Total Liabilities | Q1 2023 · Dec 31, 2022 | $220.32M |
| Current Assets | Q1 2023 · Mar 31, 2023 | $211.5M |
| Current Assets | Q1 2023 · Dec 31, 2022 | $323.75M |
| Total Assets | Q1 2023 · Mar 31, 2023 | $847.27M |
| Total Assets | Q1 2023 · Dec 31, 2022 | $963.52M |
| Eps Diluted | Q1 2023 · Mar 31, 2023 | $0.04 |
| Eps Diluted | Q1 2023 · Mar 31, 2022 | $0.70 |
| Eps Basic | Q1 2023 · Mar 31, 2023 | $0.04 |
| Eps Basic | Q1 2023 · Mar 31, 2022 | $0.71 |
| Sga Expense | Q1 2023 · Mar 31, 2023 | $32.4M |
| Sga Expense restated | Q1 2023 · Mar 31, 2022 | $23.88M |
| Net Income | Q1 2023 · Mar 31, 2023 | $1.67M |
| Net Income | Q1 2023 · Mar 31, 2022 | $34.62M |
| Operating Income | Q1 2023 · Mar 31, 2023 | −$1.62M |
| Operating Income restated | Q1 2023 · Mar 31, 2022 | −$13.39M |
| Revenue | Q1 2023 · Mar 31, 2023 | $177.98M |
| Revenue restated | Q1 2023 · Mar 31, 2022 | $166.4M |